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Objectives. The purpose of this investigation was to evaluate the
sympathetic nervous system of the heart by positron emission
tomographic (PET) imaging in patients with diabetes mellitus with
and without diabetic autonomic neuropathy .
Background. The clinical assessment of cardiac involvement in
diabetic autonomic neuropathy has been limited to cardiovascular
reflex testing . With the recent introduction of radiolabeled cate-
cholamines such as carbon (C)-I I hydroxyephedrine, the sympa-
thetic innervation of the heart can be specifically visualized with
PET imaging.
Methods. Positron emission tomographic imaging was per-
formed with C-11 hydroxyephedrine and rest myocardial blood
flow imaging with nitrogen-l3 ammonia . Three patient groups
were studied, including healthy volunteers as control subjects,
diabetic patients with normal autonomic function testing and
diabetic patients with varying severity of autonomic neuropathy .
Homogeneity of cardiac tracer retention as well as absolute tracer
retention was determined by relating myocardial tracer retention
to an arterial C-11 activity input function .
Autonomic neuropathy is associated with increased morbid-
ity and mortality in affected patients with diabetes mellitus
(1,2) and has been linked to the occurrence of sudden death
(3-7) . Between 20% and 40% of diabetic patients may have
abnormal autonomic function on clinical testing, even when
diabetes is first diagnosed (8,9) . Diabetic patients with auto-
nomic dysfunction, particularly sympathetic involvement as
evidenced by postural hypotension, have a poor clinical
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Results. Abnormal regional 011 hydroxyephedrine retention
was seen in seven of eight patients with autonomic neuropathy .
Relative tracer retention was significantly reduced in apical,
inferior and lateral segments. The extent of the abnormality
correlated with the severity of conventional mar , ers of autonomic
dysfunction. Absolute myocardial tracer retention index measure-
ments showed a 45 t 21% decrease in distal compared with
proximal myocardial segments in autonomic neuropathy (0.069 :t
0.037 min- ' vs . 0 .13 ± 0.052 min- ', p = 0.02) .
Conclusions. This study demonstrates a heterogeneous pattern
of neuronal abnormalities in patients with diabetic cardiac neu.
ropathy. The extent of this abnormality correlated with the
severity of neuropathy assessed by conventional tests . Future
studies in larger groups of patients are required to define the
relative sensitivity of this imaging approach in detecting cardiac
neuropathy and to determine the clinical significance of these
scintigraphic findings in comparison with conventional markers of
autonomic innervation .
(J Am Coll Cardiol 1993,22.1425-32)
prognosis. Their 5-year mortality rate is high, approaching
60% in one series (3,4,6) .
Little is known about the pathophysiology of cardiac
sympathetic denervation in diabetic patients because of a
prior lack of techniques to directly assess damage to sym-
pathetic neurons in the living heart .
Conventional evaluation of autonomic function utilizes
measurements of variables such as heart rate at rest, heart
rate variability during deep breathing, Valsalva ratio and
systolic blood pressure changes on standing . These indirect
measurements of autonomic function rely on the integrity of
cardiovascular reflexes and the characterization of sympa-
thetic involvement, which is often limited .
The radiotracer carbon (C)-11 hydroxyephedrine has re-
cently been developed at the University of Michigan as a
norepinephrine analogue for positron emission tomography .
Previous studies (10), using experimental models of global
and regional denervation, have demonstrated highly specific
uptake and retention of this tracer in sympathetic nerve
terminals of the heart .
The purpose of this study was to quantitatively assess
cardiac C-1 I hydroxyephedrine uptake as a marker for the
0735-1097/93156 .00
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able 1
. Clinical Characteristics and Results of Standard Autonomic Function esting
integrity of sympathetic nerve terminals and to correlate the
scintigraphic findings with conventional markers of sympa-
thetic and parasympathetic dysfunction in patients with
autonomic neuropathy . Results obtained in 8 patients with
neuropathy were compared with those from 14 healthy
volunteers and 5 diabetic patients with normal autonomic
function .
Meth
Subjects . hree patient groups were selected for study :
1)14 healthy control subjects, 2) 5 control patients with type
I diabetes without evidence of autonomic neuropathy, and
3) 8 patients with type 1 diabetes with two or more abnormal
results on standardized autonomic function testing .
No patient had a history of known cardiac disease .
Cardiac examination and an electrocardiogram (ECG) at rest
were normal in all cases . Patient data concerning age,
duration of diabetes mellitus and results of standard auto-
nomic testing are summarized in able 1. For patients with
diabetic autonomic neuropathy, other complications of dia-
betes and symptoms attributed to autonomic neuropathy are
detailed in able 2.
Patients were ineligible for the study if they had other
identified causes for neuropathy, known or suspected coro-
nary artery disease on the basis of stress testing or a history
IMb 2. Symptoms and Other Diabetic Complications in Patients
With Autonomic Neuropathy
Symptom No.
*Denotes criterion for abnormal test result . Data an expressed as number of subjects
or mean value 1 1 SI) and (range) . BP
I
= blood pressure decrease ;
F - female ; M
-
male .
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of smoking and either drug or alcohol dependence . Patients
taking investigational agents for the treatment of diabetic
neuropathy were excluded . Medications such as tricyclic
antidepressants known to interfere with neuronal uptake of
norepinephrine analogues (11) were discontinued for -e2
weeks before all studies. Written informed consent was
obtained from all patients and the study protocol was ap-
proved by the Institutional Review Board of the University
of Michigan .
Autonomic function testing. All patients underwent auto-
nomic function testing after ? 15 h abstinence from caffeine
and alcohol . At the time of testing, the patients" usual insulin
had been administered 23 h previously and blood glucose
values were in the range 5 to 15 mmollliter . Previously
published criteria (12,13) were used for interpretation of test
results.
Parasympathetic testing . Heart rate variation was mea-
sured during deep breathing at 6 breaths/min, recorded for
I min on a continuous BCG trace . Maximal and minimal RR
intervals during each respiratory cycle were recorded and
mean values for the six measured respiratory cycles were
calculated i- beats/min .
Sympathetic testing. he change in systolic blood pres-
sure during standing was assessed after 20 min of lying
supine in a quiet room. Standing systolic blood pressure was
calculated from cuff sphygmomanometer recordings at 1-min
intervals . he lowest standing systolic pressure was used to
calculate systolic postural change in blood pressure .
Combined parasympathetic and sympathetic tests . Rest
heart rate was calculated in beatslmin as a mean value
obtained over 5 min after 20 min of supine rest . he Valsalva
ratio was recorded as heart rate response during the Valsalva
maneuver against a pressure of 40 min Hg for 15 s . he ratio
of the longest RR interval after the maneuver to the shortest
RR interval during the maneuver was then calculated .
Positron emission tomogruphic (PE ) studies. Imaging
was performed in combination with C-1 I hydroxyephedrine
and nitrogen (N)-13 ammonia . hese studies were all per-
formed within 2 months of the initial clinical evaluation,
which included autonomic function testing . A transmission
study using a retractable germanium-68 ring source was
Group
No.
Age
(yr) Gender
Duration of
Diabetes
(yr)
Duration of
Autonomic
Neuropathy
(yr)
Heart Rate
at Rest
(beats/min)
X90*
Heart Rate
Variability
(beatslmin)
<8*
Valsalva
Ratio
<i,10g
Systolic BP
,,
on Standing
(mm Hg)
X30*
Healthy control
14 38 *_ 9
8M/6F
(21-44)
Diabetic control
5 37 ± 11 3M/2F
22 ± 12 - 72 ± 13 21 ± 4 .0 1 .74 ± 0.32 7 ± 6
(21-50)
(2-30) (56-90) (16-26) (1
.46-2
.30) (0-15)
Diabetic autonomic neuropathy 8
35 ± 10 2M/6F 17 ± 8
4 ® 2 92 ± 11 3 .0 ± 1 .6 1 .19 ± 0.17 21 ± 11
(19-50)
(8-31) (1-7) (77-107) (1-6)
(1
.02-1 .57) (8-38)
Nausea, vomiting, distension
C tipation
Morning '
ess
tmpotencn
Other diabetic complications
'1
7
5
5
I
Diabetic nephr
thy
5
PrdWrative retinopathy
5
Icy 5
tetinopathy
4
Amputation for osteomyelitis
1
Foot ulcers
1
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acquired to subsequently correct emission data for attenua-
tion . Imaging of the heart was performed with 20 mCi of C- I I
hydroxyephedrine over 60 min (14) . racer was injected
intravenously and data were acquired dynamically in frame
mode to determine tracer activity in both blood and myocar-
dium. After waiting I h for C- I I decay after the end of data
acquisition, myocardial perfusion at rest was evaluated using
20 mCi of N-13 ammonia. A 10-min static acquisition was
performed, commencing 3 min after injection .
Homogeneity of C-11 hydroxyephedrine retention . o
assess homogeneity of C-11 hydroxyephedrine and N-13
ammonia retention, a semiquantitative approach was used .
A sequence of eight short-axis images of the left ventricle
was used for analysis of the blood flow and 30- to 40-min
postinjection C- I I hydroxyephedrine data . Circumferential
count-profile analysis was performed on these images, with a
radial search for maximal activity in 36 equal sectors around
the circumference of the ventricle (15) . his search was
constrained within operator-defined endocardial and epicar-
dial borders . Individual profiles were generated for each
image and then all profiles were normalized to the highest
myocardial value (3 x 3 pixels) found in the entire data set
.hese data were displayed as polar coordinate maps of
relative tracer activity (Fig . I and 2) . he map was divided
into nine regions as depicted schematically in Figure 3 .
Within each region, the mean tracer activity value was
expressed as a percent of the maximal activity in the map
(Fig. 3) .
Studies performed in the volunteers were averaged to
form a data base of normal values for homogeneity of flow
and C-11 hydroxyephedrine retention . Patient polar maps
were compared with the data base, and map pixels with
values >2 .5 SD were defined as abnormal . he extent of
heterogeneity was expressed as the percent of the map with
values >2 .5 SD of control values .
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Figure 1 . Left, Patient with early diabetic autonomic neuropathy
and abnormalities of the parasympathetic system on standard test-
ing. Flow and C- I I hydroxyephedrine (HED) images appear normal .
Right, Polar maps show homogeneous N-13 ammonia retention (left)
but a small (3% of the left ventricular map area) region in the distal
inferolateral wall with heterogeneous C- I I hydroxyephedrine reten-
tion >2.5 SD less than control values (right) . he C- I I hydroxy-
ephedrine retention index showed a 48% reduction in distal
(0.065 min - ') compared with proximal myocardium (0 .090 min - ') .
Myocardial C-11 hydroxyephedrine retention index . o
quantitatively assess the severity of reduced tracer uptake,
we measured absolute C-11 hydroxyephedrine retention in
both the proximal and the distal left ventricular myocardium .
Absolute tissue retention of C- I I hydroxyephedrine between
30 and 40 min after injection was measured for distal (plane
4) and proximal (plane 10) myocardial slices . Mean tracer
counts/pixel within the myocardial region were determined .
o correct this measurement for amount of tracer delivered
to the myocardium, retention was divided by total counts in
the blood over the time period from injection to 40 min later .
otal blood counts were determined from the area under the
time-activity curve for a small region of interest (3 x 3
pixels) placed in the center of the left ventricular blood pool
on a basal plane . his yielded a C-11 hydroxyephedrine
retention index as follows :
issue counts between 30 to 40 min
Retention index (min-1) =
_	
f Blood counts from time 0 to 40 min
Relation between myocardial blood flow and C-11 hy-
droxyephedrine retention .
Myocardial C-11 hydroxyephe-
drine retention has been previously shown to be flow-related
(16) . o further demonstrate that reduced C-11 hydroxy-
ephedrine retention represented decreased uptake in nerve
terminals rather than reduced tracer delivery, the ratio of
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Figure 2. Left, Contrasting example in a patient with advanced
diabetic autonomic neuropathy with symptomatic postural hypoten-
sion . Blood flow images again appear normal visually, but C-1l
hydroxyephedrine images show regional heterogeneity of tracer
retention throughout the distal and proximal anterolaterai and
inferior walls, Right, Polar maps (lower panel) again show homoge-
neous N-13 ammonia retention but heterogeneous C-11 hydroxy
eephedrine retention, with 83% of the map decreasing to >2 .5 SD less
than control values . he retention index showed a reduction of 87
in distal (0 .027 min") versus proximal (0 .14 min-) myocardium .
regional C-1 l hydroxyephedrinelflow counts expressed as a
percent of maximum in the heart was plotted for combined
proximal, distal and apical segments in each patient and
subiect group .
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Statistics . Data are expressed as mean value ± I SD .
Differences in group means were compared using the Mann-
Whitney U test, Wilcoxon rank sum test or Kruskal-Wallis
test . Relations between continuous variables were compared
by linear regression using a least-squares technique, with
calculation of the Pearson correlation coefficient r and t test
for significance of the slope of the regression line . Values of
p < 0.05 were considered statistically significant .
Results
Autonomic function testing. he results of autonomic
function testing in group 2 (diabetic control subjects with
normal autonomic test results) and group 3 (diabetic patients
Figure3. Maps of relative regional C-I 1 hydroxyephedrine
retention derived from circumferential profile analysis .
Values are mean t I SD within each region expressed as
percent of maximal activity in the map . Healthy control
subjects and diabetic control patients show homogeneous
C-I 1 hydroxyephedrine distribution, whereas patients with
diabetic autonomic neuropathy show heterogeneous C-1l
hydroxyephedrine uptake in the apical, inferior and lateral
walls. *p = 0 .003 versus healthy control subjects ; 1p =
0.008 versus diabetic control patients ; tp = 0 .008 versus
healthy control subjects ; §p = 0 .009 versus healthy control
subjects.
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with abnormal autonomic test results) are summarized in
able 1 . Of the eight patients with autonomic neuropathy,
two had results suggesting parasympathetic dysfunction
only, with heart rate variability being the single abnormal
finding . he remaining six patients had evidence of com-
bined parasympathetic/sympathetic dysfunction, with ab-
normal heart rate variability, Valsalva ratio or blood pres-
sure response .
Illustrative cases . Examples of PE images and
accom-
panying
polar map representations of circumferential count-
profile analysis of the images are depicted for two patients,
one with parasympathetic and the other with combined
autonomic dysfunction (Fig. I and 2) .
Figure 1 shows PE images from a 19-year old woman
with an 8-year history of diabetes mellitus and findings
indicative prLa4dly of parasympathetic dysfunction : ele-
vated heart rate at rest of 100 beats/min (normal <90) and
decreased heart rate variability 6 beats/min (normal -> 12) but
without postural hypotension or decreased Valsalva ratio .
Blood flow images appeared normal on visual inspection, but
C- I I hydroxyephedrine images demonstrated a subtle reduc-
tion in tracer retention in the distal inferior wall of the left
ventricle. Polar maps showed homogeneous distribution of
N-13 ammonia. However, there was a small (3 .5%) region of
abnormal tracer retention in the distal inferior left ventricle,
and the tracer retention index showed a 48% reduction in
distal (0.065 min - ) compared with proximal (0 .090 min - ')
myocardium .
he example in Figure 2 represents the PE study of a
44-year-old man with a 19-year history of diabetes mellitus
and severe autonomic neuropathy involving both parasym-
pathetic and sympathetic divisions : reduced heart rate vari-
ability 2 beats/min (normal >12), postural hypotension
30 mm Hg and Valsalva ratio reduced to 1 .02 (normal
>1 .21). Blood flow images again appeared normal visually,
but C- I I hydroxyephedrine images showed regional reduc-
tion of tracer retention in the distal and proximal antcro-
lateral and inferior walls . Polar maps again showed homo-
geneous N-13 ammonia distribution but reduced C-11
hydroxyephedrine retention (83% of the map area) . he
retention index showed a reduction of 87% in distal
(0.027 min- ') versus proximal myocardium (0.14 min- ') .
Regional C-11 hydroxyephedrine retention in diabetic
autonomic neuropathy . Nitrogen-13 ammonia retention
throughout the left ventricle was homogeneous in all the
diabetic patients. Flow abnormalities were <2% of the left
ventricular map area in all images . Maps of mean relative
C -I I hydroxyephedrine retention expressed as percent of
maximum in the heart are shown in Figure 3 for all three
groups of patients. Homogeneous tracer retention through-
out the left ventricular map was seen for the healthy control
subjects (mean value 75 ± 8%) and diabetic control patients
(mean value 79 ± 6%) . However, there was regionally
reduced C-11 hydroxyephedrine retention in diabetic pa-
tients with autonomic neuropathy (65 ± 18%, p < 0 .05) . In
the diabetic patients with autonomic neuropathy, decreased
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100 -
80 0
60 0
0
40
20
0 4
0
ALLMAN E
AL
P=.009
-01
0
_00AW
diabetic diabetic
autonomic control
neuropathy
patients
Figure 4 .
he abnormality of left ventricular (LV) C- I I hydroxy-
ephedrine retention expressed as the extent of myocardium repre-
sented on the polar map >2 .5 SD less than control values was
significantly greater in diabetic patients with versus without auto-
nomic neuropathy (p = 0,009) .
I
tracer retention involved the apical segment (33% less than
the value in healthy control subjects, p = 0 003 and 32 % less
than the value in diabetic control patients, p = 0 .008) ; distal
inferior segment (32% less than the value in healthy control
subjects, p = 0.008), and distal lateral segment (33% less
than the value in healthy control subjects, p = 0 .009).
he extent of regional C- I I hydroxyephedrine retention
abnormalities is plotted in Figure 4 for the two groups of
diabetic patients. Such abnormalities were detected in seven
of eight patients with autonomic neuropathy (mean 32 t 33%
of the left ventricular map area, range 0% to 83%) and one
diabetic control patient (3% of the left ventricular map area) .
Four patients in the study had small (2% to 4% of the left
ventricular map area) regions of reduced retentior of C- I I
hydroxyephedrine and these were located in the distal
inferior wall toward the apex . he remaining four patients
had abnormalities ranging from 47% to 83% of the left
ventricular map area, involving both distal and proximal
segments .
Absolute tissue retention index for C-11 hydroxyephedrine
in distal versus proximal myocardium . Measurements of
absolute tissue retention index for W I hydroxyephedrine in
proximal and distal segments are shown in Figure 5 for all
three groups of patients studied . here was a significant
reduction in retention from proximal through distal myocar-
dium in the patients with diabetic autonomic neuropathy
(0.13 ± 0.052 vs . 0 .069 t 0.037 min - ', p = 0.02) not seen in
the diabetic control patients (0 .12 ± 0 .017 vs . 0.12 ± 0 .019,
min- ', p = 0.70) or in the healthy control subjects (0 .11
0.02 vs . 0.11 ± 0.03 min- , p = 0.94) .
C-11 hydroxyephedrine/flow ratios
. Carbon-11 hydroxy-
ephedrine/flow ratios in proximal, distal and apical segments
are shown for all three patient groups in Figure 6 . Values
close to unity were obtained in
all segments in healthy
1429
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Figure 5. Patients with diabetic autonomic neuropathy showed a
reduction in distal compared with proximal myocardial C-I1 hy-
droxyephedrine (HED) retention index (p < 0 .01) . his pattern was
not observed in healthy control subjects or diabetic control patients .
LV - left ventricle .
control subjects and diabetic control patients . However, in
patients with diabetic autonomic neuropathy, there was a
progressive reduction in ratio from the proximal to distal to
apical myocardium (p = 0 .0001). Ratios in all segments were
significantly reduced in this group compared with values in
control subjects and in patients with long-standing diabetes .
Relation between standard autonomic tests and scinti-
graphic findings in patients with diabetic autonomic neuro-
pathy. he extent and severity of C-11 hydroxyephedrine
reduction was related to the severity of autonomic dysfunc-
tion as assessed by conventional testing, 1) As the nu;~,tr )f
abnormal standard test results increased, there was a corre-
sponding decrease in C-I I hydroxyephedrine retention index
in the distal myocardium (r = 0.80, p = 0 .04). 2) Both the
extent of abnormal C-11 hydroxyephedrine mention by
Figure 6. Carbon-11 hydroxyephedrine (HED)Iflow ratios for all
three patient groups
. Values were near unity in all sites in healthy
and diabetic control patients, but in diabetic patients with autonomic
neuropathy, they were progressively reduced from proximal to
distal to apical myocardium . *p < 0.001 for patients with autonomic
neuropathy versus healthy control and diabetic patients ; tp < 0 .01
for patients with autonomic neuropathy versus healthy control
subjects and p < 0.001 for patients with autonomic neuropathy
versus diabetic control patients . LV = left ventricle .
distal LV
® Wnvols
apex
niroeome
na'uroperhy
polar map analysis and the severity of reduction in distal left
ventricular C-I I hydroxyephedrine absolute retention index
were related to the decrease in systolic blood pressure (r
0.89, p = 0 .003 and r = 0.77, p = 0.03, respectively) . 3) he
extent of heterogeneous C-I l hydroxyephedrine retention in
patients with postural hypotension a30 mm Hg was 67 ±
14% of the left ventricular map area versus 11 ± 20% of the
left ventricular map area in those with postural hypotension
<30 mm Hg (p = 0.02) (Fig. 7) .
Discussion
his study provides new information about diabetic sym-
pathetic neuropathy in the human heart as assessed nonin-
vasively by C-11 hydroxyephedrine in combination with
PE imaging . he scintigraphic results in this patient group
demonstrate a regional reduction in C-I 1 hydroxyephedrine
retention, commencing distally in the left ventricle, then
with more severe autonomic neuropathy, spreading both
circumferentially and proximally, involving anterior, inferior
and lateral walls . he absolute C-11 hydroxyephedrine re-
tention index was lower in distal than in proximal myocardial
segments, a pattern seen only in patients with diabetic
autonomic neuropathy and not in healthy control subjects or
diabetic control patients .
C-11 hydroxyephedrine as tracer for neuronal injury.
Myocardial C-11 hydroxyephedrine retention has been pre-
viously demonstrated to be specific for sympathetic neurons
in the heart by experimental and clinical studies performed
in this laboratory using pharmacologic intervention and
studies in patients after heart transplantation (14,17) .
he healthy volunteers and diabetic patients without
evidence of neuropathy demonstrated homogeneous C-I1
hydroxyephedrine retention throughout the left ventricle . In
contrast, patients with diabetic autonomic neuropathy dis-
played a unique scintigraphic pattern, indicating progression
of neuronal abnormalities from the apex toward the base of
the left ventricle .
his scintigraphic observation suggests that cardia, . neu-
ropathy starts in the most distal sites of sympathetic nerve
fibers and progresses proximally with time. A similar length-
dependent pattern of neuropathy was described in the pe-
ripheral nerves of patients with diabetes mellitus (18) .
Despite extensive investigation of the biochemical mech-
anisms and structural abnormalities of neurons related to
development of diabetic neuropathy, the current under-
standing of the pathophysiology of this condition remains
incomplete. Proposed mechanisms of neuronal damage in-
clude metabolic abnormalities, neuronal ischemia and
immune-mediated injury (18,19) .
he scintigraphic approach employed in this study uti-
lizes C-11 hydroxyephedrine retention in cardiac neuronal
tissue as a marker for the integrity of sympathetic nerve
terminals. Carbon-I1 hydroxyephedrine competes with nor-
epinephrine (10) for the energy-dependent neuronal cate-
cholamine transport system (uptake-1) and vesicular storage
JACC Vol . 22, No . 5
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Figure 7. Abnormal C- I I hydroxyephe-
drine retention >2 .5 SD less than control
values involved significantly more of the
left ventricle (LV) in patients with dia-
betic autonomic neuropathy and postural 20 ~
hypotension (p = 0 .02).
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mechanisms . Unlike norepinephrine, it is not metabolized
within the neuron by the monoamine oxidase . ' here are
several possible reasons for a decrease in tissue C- I I hy-
droxytephedrine retention . First, increased levels of circulat-
ing norepinephrine may compete with C- I I hydroxyephe-
drine for uptake-I . However, such competition would be
expected to affect the whole heart in a homogeneous fashion
and is unlikely to explain the regional abnormalities ob-
served in this stud . Second, decreased function of either or
both the uptake-I and vesicular storage mechanisms may
occur in diabetic autonomic neuropathy . Although the use of
C-1 I hydroxyephedrine does not allow the differentiation
between uptake or storage abnormalities in the sympathetic
nerve terminal, newer tracers with varying affinity for neu-
ronal uptake and storage are currently being evaluated in our
laboratory (20,21) .
Finally, reduced C- I I hydroxyephedrine retention may
indicate loss of neurons that have become irreversibly dam-
aged . o determine whether scintigraphic findings observed
in this study are due to irreversible or potentially reversible
functional disturbances of sympathetic neurons, longitudinal
scintigraphic studies in patients receiving therapy aimed at
altering the natural history of diabetic neuropathy are re-
quired (19)
.
Carbon-] I hydroxyephedrine is metabolized in the liver
and C- I I metabolites are released into the vascular space .
he input function used for the calculation of the retention
index has not been corrected for C- I l -labeled metabolites,
assuming similar metabolic fate in all patients . he close
agreement of values for tracer retention in healthy volun-
teers and diabetic patients without neuropathy indicate little
variation in C- I I hydroxyephedrine mmabolism among indi-
viduals .
Comparison with standard autorwanit testing. here was
significant correlation between results of C- I I hydroxy-
ephedrine scintigraphy and conventional autonomic function
test findings . he patients displayed a wide range of auto-
nomic dysfunction as reflected in their symptoms and stan-
dard test results. hose patients with the most severe
sympathetic neuropathy had the most abnormal scinti-
graphiz findings
. However, three patients with normal sym-
pathetic function test results had abnormal C-11 hydroxy-
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Wyetalle blood pressure i1ell on standing
ephedrine scintigraphic findings . he finding that patients
may have regional abnormalities of C -I I hydroxyephedrine
retention without postural hypotension or an abnormal Val-
salva ratio, both markers of sympathetic dysfunction, sug-
gests that PE
imaging may be more sensitive for detecting
early sympathetic nervous system dysfunction than is an
abnormal blood pressure response, which may not be elic-
ited until a later stage in the neuropathic process . wo
patients in the study with only increased heart rate at rest
and decreased heart rate variability, suggesting primarily
parasympathetic abnormalities, displayed slight C-11 hy-
droxyephedrine abnormalities . However, a larger group of
patients, with varying degrees of autonomic dysfunction and
more sophisticated tests, such as spectral analysis of heart
rate variability, are needed to dissect the relation between
sympathetic and parasympathetic neuropathy and the scin-
tigraphic findings . Furthermore, the use of new tracers for
assessing parasympathetic function (22), which is affected
earlier than the sympathetic division in diabetic autonomic
neuropathy (2,23,24), may offer a more complete evaluation
of the integrity of the cardiac autonomic innervation through
the use of combined tracer approaches .
Potential implications. Carbon-11 hydroxyephedrine
combined with PE
imaging represents a unique research
tool for the noninvasive quantification of diabetic sympa-
thetic neuropathy . In these patients, C- I I hydroxyephedrine
scintigraphy appeared to be a sensitive marker for the
detection and quantification of sympathetic dysfunction,
with abnormalities detected in all patients with abnormal
sympathetic function test results and in three patients with-
out abnormal sympathetic test findings . Carbon- I I hydroxy-
ephedrine scintigraphy thus extends the regional assessment
of cardiac sympathetic function further than has been pos-
sible with cardiovascular reflex function testing and may
provide new insights into the natural history of neuropathy
.
Measurements of nerve conduction velocity, axonal
transport and autonomic function in animal models of dia-
betic neuropathy have shown improvement in the response
to therapy with aldose reductase inhibitors (19)
. However,
little is known about whether these agents may alter the
progression of diabetic autonomic neuropathy in humans
.
Carbon-11 hydroxyephedrine scintigraphy may provide a
combined
autonomic
dysfunction
parasympathetic
dysfunction
or0y
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noninvasive approach to the objective quantification of
response to such therapy in longitudinal studies .
Conclusions. In selected diabetic patients with autonomic
neuropathy, this study demonstrated regional abnormalities
of myocardial C-ll hydroxyephedrine retention that corre-
lated with the severity of abnormalities on standard testing .
his scintigraphic information provides new insights into the
possible pathophysiology of autonomic neuropathy in the
human heart . In the future, C-11 hydroxyephedrine com-
bined with tracers of the parasympathetic division of the
autonomic nervous system may allow more complete quan-
titative evaluation of autonomic neuropathy in diabetic pa-
tients. Further studies in larger groups of patients are
warranted to explore the clinical role of this approach in the
assessment of autonomic dysfunction in these patients .
We express our thanks to the University of Michigan medical cyclotron and
radiochemistry unit for the production of C-I 1 hydroxyephedrine and to the
PE suite technologists for performing the scintigraphic studies . echnical
assistance with data analysis was provided by Ngoc Nguyen, BS and Otto
Muzik, PhD,
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